Page 0004






Commenting on a report from the JDRF/Wellcome Trust scientific conference on the cross

mechanisms of autoimmune diseases Professor John Todd, University of Cambridge,

a leading expert in the genetics of type 1 diabetes, emphasised the importance of this

area of research saying that while autoimmunity is common, affecting five per cent of the

population, "it is not well treated yet, despite years of study." Read more here.

The Eurodiab Prospective Complications Study looked at glyceamic control and

the mortality risk in Type 1 diabetes patients. Glycemic targets, such as the HbA1c

target, and the overall benefit of intensive glucose control are currently under debate

as intensive glycemic control has been suggested to have negative effects on mortality

risk in Type 2 diabetes patients. The report examins the association between glycated

hemoglobin (HbA1c) and all-cause mortality in patients with Type 1 diabetes mellitus.

The study was performed in 2,764 European patients with Type 1 diabetes aged 15-60

years enrolled in the Eurodiab Prospective Complications Study and was collated over

a seven-year period.

It was found that all-cause mortality risk was increased at both low (5.6%) and high

(11.8%) HbA1c compared to the reference (median HbA1c: 8.1%). The report concluded

that target HbA1c below a certain threshold may not be appropriate in Type 1 diabetics.

Read the full article here.

Our free online magazine

for people with diabetes

sent to your inbox each month.

News, views, reviews, features,

free samples and giveaways.

Sign up with your email address!

email address

Medtronic's Junior Cup Diabetes 2014

takes place this year from the 22nd-

24th August in Sports Centre Papendal

in Arnhem, Holland. The event is aimed

at boys and girls with type 1 diabetes

using an insulin pump who have not yet

participated in Junior Cup Diabetes and

who are between the ages of 10-14.

They need to be available to travel to

the Netherlands for 22nd - 24th August

2014. Registration closes on the 30th

June 2014. To be in with a chance of

representing the UK and Ireland in the

Junior Cup Diabetes 2014 visit

The United Kingdom Prospective

Diabetes Study, and Diabetes Control

and Complications Trial have shown

that aggressive glucose control,

especially early in the natural history of

the disease, might result in a significant

reduction of microvascular as well as

macrovascular complications.

However, more recent trials have

increased the level of complexity of

the relationship between 'tight glucose


control/chronic complications', with several

factors influencing the risk-to-benefit ratio

to be considered, such as age, presence

of established complications and diabetes

duration. According to this strategy, a

more intensive goal is desirable for young

patients with no cardiovascular disease,

whereas less stringent control is suitable

for all people who are relatively late in the

natural history of diabetic complications.

Numerous calls for an individualized

therapy have been proposed during the

past years, but still debated is the level

of glucose lowering necessary to reduce

complications balanced by the risk and

costs of the means used. The present

paper briefly reviews the rationale and the

clinical trials that support specific glycemic

goals towards a 'tailored' approach for

the management of hyperglycemia in



  1. Desang diabetes magazine diabetes information
  2. Bayer Contour Link USB blood test meter for Medtronic insulin pump
  3. Desang diabetes magazine diabetes information
  4. Page 0004
  5. Abbott FreeStyle Libre System
  6. Sitting is the new enemy
  7. Needle sharps Needlebay
  8. Diabetes food news
  9. Accu-Chek Mobile blood glucose system
  10. Diabetes and Sleep
  11. Diabetes and sleep
  12. night time hypos
  13. Simple sleep solutions for diabetes
  14. Carbohydrate value of olives and olive oil
  15. Carb content of olives
  16. Counting carbohydrates
  17. Accu-Chek Combo insulin pump
  18. Desang diabetes kitbags

Related Issues